Assessment
bictegravir/emtricitabine/tenofovir alafenamide
HIV-1 infection in children and adolescents aged 2 years and older weighing at least 14 kg, with no current or past resistance to integrase inhibitors, emtricitabine or tenofovir
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relations